October 5, 2020 | software | No Comments
Clinical trials into a COVID-19 vaccine as well as research into other diseases have been delayed following a ransomware attack on a company that provides software to medical firms.
First reported Saturday by The New York Times, the attack targeted eResearchTechnology Inc., a Philadelphia-based company that specializes in clinical software. The attack is said to have been detected two weeks ago when employees discovered they were locked out of their data by ransomware.
As a result of the ransomware attack, companies using ERT’s software were also affected. Among those were IQVIA Inc., a research organization helping managing AstraZeneca plc’s coronavirus vaccine trial, and Bristol Myers Squibb Co., a drug company leading a consortium of companies developing a quick COVID-19 test.
Clinical trial patients were not affected, but researchers were forced to resort to pen and paper to track patients.
How many companies and health organizations have been affected is unknown.